GleamWall
中文EN

CURLF Curaleaf Holdings, Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1756770 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-0.9%
TTM net income YoY23.4%
TTM EPS YoY17.9%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR—

Margins

Gross margin48.0%
Operating margin1.9%
Net margin-16.1%
FCF margin5.3%
EBITDA margin19.2%

Returns

ROE-22.5%
ROA-7.1%
ROIC (approx.)1.4%
Asset turnover0.44x

Leverage & solvency

Liabilities / assets66.3%
Debt / equity0.66x
Current ratio1.12x
Interest coverage0.47x

Cash quality & payout

Operating cash flow / net income-0.76x
Accruals ratio-12.5%
Payout ratio—
Capex / revenue6.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.27B$1.33B$1.35B$1.28B$1.20B
Cost of revenue$637.11M$693.52M$732.18M$649.00M$626.16M
Gross profit$631.02M$640.78M$614.45M$626.42M$569.83M
R&D expense$805,000$1.42M———
SG&A expense$428.44M$418.53M$414.77M$419.88M$386.64M
Operating income$25.45M$24.74M$42.88M$64.99M$58.57M
Interest expense$53.52M$53.19M$53.71M—$53.55M
Pretax income-$78.21M-$113.36M-$124.37M-$86.49M-$62.20M
Income tax$123.69M$98.25M$114.59M$178.82M$152.44M
Net income-$231.07M-$215.42M-$281.20M-$370.10M-$205.94M
EBITDA$222.06M$256.20M$238.76M$220.97M$179.12M
EPS (basic)-0.35-0.32-0.39-0.52-0.29
EPS (diluted)-0.35-0.32-0.39-0.52-0.29
Weighted avg. shares (diluted)762.09M740.83M724.12M711.16M698.76M
Balance sheet
Cash & equivalents$89.21M$107.22M$91.82M$163.18M$299.33M
Receivables$73.86M$63.99M$60.00M$45.18M$60.43M
Inventory$225.02M$216.94M$215.91M$234.78M$248.15M
Current assets$448.62M$434.37M$418.60M$652.42M$726.62M
PP&E, net$520.39M$542.60M$571.63M$595.85M$525.83M
Goodwill$635.12M$628.88M$626.63M$625.13M$571.65M
Intangibles$1.01B$1.09B$1.17B$1.21B$1.04B
Total assets$2.85B$2.95B$3.10B$3.41B$3.11B
Current liabilities$294.31M$387.93M$494.03M$496.87M$316.24M
Short-term debt$35.73M$101.72M$39.48M$51.88M$1.97M
Long-term debt$512.92M$466.90M$548.29M$570.79M$457.92M
Total debt$548.65M$568.62M$587.77M$622.67M$459.88M
Total liabilities$2.01B$1.96B$1.93B$2.01B$1.44B
Shareholders' equity$756.35M$861.21M$1.05B$1.28B$1.55B
Net debt$459.44M$461.39M$495.95M$459.49M$160.55M
Shares outstanding257.49M750.06M733.73M717.49M708.34M
Cash flow statement
Operating cash flow$137.71M$163.62M$75.26M$46.40M-$58.28M
Capital expenditure$63.44M$92.44M$65.45M$134.64M$171.96M
Free cash flow$74.27M$71.19M$9.81M-$88.24M-$230.24M
Investing cash flow-$70.34M-$93.83M-$78.69M-$219.88M-$163.97M
Financing cash flow-$73.49M-$54.24M-$67.02M$41.79M$449.12M
Depreciation & amortization$196.61M$231.46M$195.88M$155.98M$120.54M
Stock-based compensation$35.74M$25.70M$20.01M$28.02M$39.48M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.